Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: Comparing to influenza like illness and volunteer controls

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Zhan, Yangqing ^a   Yang, Zifeng ^a   Chen, Rongchang ^a   Wang, Yutao ^a   Guan, Wenda ^a   Zhao, Suishan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell culture; Clinical feature; Community acquired pneumonia; Seroconversion; Viral disease

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADENOVIRUS; ADULT; AGED; ARTICLE; CELL CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; CORONAVIRUS; DISEASE SEVERITY; ESCHERICHIA COLI; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; GENE AMPLIFICATION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN RHINOVIRUS; IMMUNOFLUORESCENCE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYALGIA; OBSERVATIONAL STUDY; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PROSPECTIVE STUDY; RESPIRATORY VIRUS; SMOKING; SPUTUM; STENOTROPHOMONAS MALTOPHILIA; THROAT CULTURE; VIRUS ETIOLOGY; VIRUS PNEUMONIA; ADENOVIRIDAE; ADENOVIRUS INFECTION; BLOOD; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; CORONAVIRIDAE; CORONAVIRUS INFECTION; HUMAN PARAINFLUENZA VIRUS 1; HUMAN PARAINFLUENZA VIRUS 3; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; NORMAL HUMAN; PICORNAVIRUS INFECTION; RESPIROVIRUS INFECTION; RHINOVIRUS; RNA VIRUS INFECTION; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADULT; AGED; ANTIBODIES, VIRAL; COINFECTION; COMMUNITY-ACQUIRED INFECTIONS; CORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PARAINFLUENZA VIRUS 1, HUMAN; PARAINFLUENZA VIRUS 3, HUMAN; PICORNAVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; RESPIROVIRUS INFECTIONS; RHINOVIRUS; RNA VIRUS INFECTIONS;

EID: 84908136966     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-144     Document Type: Article

References (32)

1. File TM. Community-acquired pneumonia. Lancet 2003, 362:1991-2001. 10.1016/S0140-6736(03)15021-0, 14683661.
2. Smith W, Andrews C, Laidlaw P. A virus obtained from influenza patients. Lancet 1933, 222:66-68.
3. Jennings LC, Anderson TP, Beynon KA. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008, 63:42-48. 10.1136/thx.2006.075077, 17573440.
4. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community acquired pneumonia: prevalence, pathogens and presentation. Chest 2008, 134:1141-1148. 10.1378/chest.08-0888, 18689592.
5. Angeles Marcos M, Camps M, Pumarola T, Antonio Martinez J, Martinez E, Mensa J, Garcia E, Peñarroja G, Dambrava P, Casas I, de Anta MT J, Torres A. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther 2006, 11:351-359.
6. Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R, Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010, 138:811-816. 10.1378/chest.09-2717, 20363845.
7. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160:397-405. 10.1164/ajrccm.160.2.9808045, 10430704.
8. Respiratory Branch of Chinese Medical Association Diagnosis and therapy guideline of community acquired pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2006, 29:651-655. Respiratory Branch of Chinese Medical Association.
9. Kubo T, Nishlmura H. Antipycetie effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children. Phytomedicine 2007, 14:96-101. 10.1016/j.phymed.2006.09.015, 17141491.
10. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37:937-943. 88628, 10074505.
11. Yang ZF, Wang YT, Qin S, Luo Y, Guan WD, Li JQ, Zhan Y, Zhang X, Zhou R, Mo Z, Chen JX, Chen RC. A study of detection of respiratory viruses from patients with influenza like illness in Guangzhou using centrifugation-enhanced shell vials, between January and May, 2009. Chinese J Laboratory Med 2010, 33:1-6.
12. Dakhama A, Hegele RG, Laflamme G, Israël-Assayag E, Cormier Y. Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999, 159:1316-1322. 10.1164/ajrccm.159.4.9807085, 10194183.
13. World Health Organization Guidance to influenza laboratories: diagnosing swine influenza A/H1N1 infections of current concern Online at http://www.who.int/entity/csr/disease/swineflu/swineflu_guidance:labs_20090427.pdf. Accessed 30 April 2009, World Health Organization.
14. Liu WK, Chen DH, Liu Q, Liang HX, Yang ZF, Qin S, Zhou R. Detection of Human Bocavirus from Children and Adults with Acute Respiratory Tract Illness in GuangZhou. Southern China BMC Infectious Diseases 2011, 11:345.
15. de Roux A, Ewig S, García E, Marcos MA, Mensa J, Lode H, Torres A. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006, 27:795-800. 10.1183/09031936.06.00058605, 16585087.
16. de Roux A, Marcos MA, Garcia E, Mensa J, Ewig S, Lode H, Torres A. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest 2004, 125:1343-1351. 10.1378/chest.125.4.1343, 15078744.
17. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011, 377:1264-1275. 10.1016/S0140-6736(10)61459-6, 21435708.
18. Gencay M, Roth M, Christ-Crain M, Mueller B, Tamm M, Stolz D. Single and multiple viral infections in lower respiratory tract infection. Respiration 2010, 80:560-567. 10.1159/000321355, 20861611.
19. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P. Study of community acquired pneumonia etiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001, 56:296-301. 10.1136/thorax.56.4.296, 1746017, 11254821.
20. Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML., Australian CAP Study Collaboration The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008, 46:1513-1521. 10.1086/586749, 18419484, Australian CAP Study Collaboration.
21. Huijskens EG, van Erkel AJ, Palmen FM, Buiting AG, Kluytmans JA, Rossen JW. Viral and bacterial aetiology of community-acquired pneumonia in adults. Influenza Other Respi Viruses 2013, 7(4):567-573.
22. Centers for Disease Control and Prevention (CDC) Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. Morbid Mortal Wkly Rep 2009, 58:467-470. Centers for Disease Control and Prevention (CDC).
23. Yang ZF, Zhan YQ, Chen RC, Zhou R, Wang YT, Luo Y, Jiang M, Li JQ, Qin S, Guan WD, Lai KF, Wen HL, Liang ZW, Li L, Zhong NS. A prospective comparison of the epidemiological and clinical characteristics of pandemic (H1N1) 2009 influenza A virus and seasonal influenza A in Guangzhou, South China in 2009. Jpn J Infect Dis 2012, 65:208-214. 10.7883/yoken.65.208, 22627301.
24. Ko FW, Ip M, Chan PK, Ng SS, Chau SS, Hui DS. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia. Respir Med 2008, 102(8):1109-1116. 10.1016/j.rmed.2008.03.019, 18573648.
25. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. Fields Virology 2007, 1691-1732. Pa. USA: Lippincott Williams & Wilkins, Knipe DM, Howely PM.
26. Oxford JS. Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses 2007, 1:27-34.
27. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005, 192:249-257. 10.1086/430954, 2715995, 15962219.
28. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970. 10.1086/591708, 2599911, 18710327.
29. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald LC. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006, 12:894-899. 10.3201/eid1206.051141, 3373026, 16707043.
30. Carrat F, Schwarzinger M, Housset B, Valleron AJ. Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays. Eur J Epidemiol 2004, 19:703-705.
31. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363:600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
32. Friis B, Andersen P, Brenøe E, Hornsleth A, Jensen A, Knudsen FU, Krasilnikoff PA, Mordhorst CH, Nielsen S, Uldall P. Antibiotic treatment of pneumonia and bronchiolitis. Arch Dis Child 1984, 59:1038-1045. 10.1136/adc.59.11.1038, 1628797, 6391389.